Zacks Investment Management’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Zacks Investment Management’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-43,690	Closed	-$83K	–	631
2018 Q2	$83K	Buy	+43,690	New	+$88.3K	﹤0.01%	535
2017 Q3	–	Sell	-64,586	Closed	-$101K	–	676
2017 Q2	$101K	Buy	+64,586	New	+$125K	﹤0.01%	572
2016 Q2	–	Sell	-18,660	Closed	-$98K	–	728
2016 Q1	$98K	Buy	+18,660	New	+$114K	﹤0.01%	593

Other funds holding INFI

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Zacks Investment Management's INFI Position: Q3 2018 in Review

Zacks Investment Management sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q3 2018, closing a stake of 43,690 shares — an estimated $83K sold.

Zacks Investment Management first reported a position in INFI in Q1 2016 and held it in 3 quarters. The position peaked at $101K in Q2 2017. 63 funds tracked by Wall St. Rank hold INFI as of Q3 2018.

Zacks Investment Management reported no remaining Infinity Pharmaceuticals, Inc. position as of Q3 2018 after selling out during the quarter.
Zacks Investment Management sold 43,690 Infinity Pharmaceuticals, Inc. shares in Q3 2018, an estimated $83K.
Zacks Investment Management first reported a position in Infinity Pharmaceuticals, Inc. in Q1 2016 and held it in 3 quarters.
Zacks Investment Management's Infinity Pharmaceuticals, Inc. position peaked at $101K in Q2 2017.
63 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q3 2018.

Based on Zacks Investment Management's 13F filing for Q3 2018, filed 14 Nov 2018.